Edwards Lifesciences (EW) Total Debt Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.11% |
| Dec 31, 2025 | 0.11% |
| Sep 30, 2025 | 0.11% |
| Jun 30, 2025 | 0.11% |
| Mar 31, 2025 | 0.11% |
| Dec 31, 2024 | 0.11% |
| Sep 30, 2024 | 0.11% |
| Jun 30, 2024 | 0.11% |
| Mar 31, 2024 | 0.11% |
| Dec 31, 2023 | 0.11% |
| Sep 30, 2023 | 0.11% |
| Jun 30, 2023 | 0.09% |
| Mar 31, 2023 | -10.77% |
| Dec 31, 2022 | 4.00% |
| Sep 30, 2022 | -11.13% |
| Jun 30, 2022 | -10.13% |
| Mar 31, 2022 | -6.81% |
| Dec 31, 2021 | -6.24% |
| Sep 30, 2021 | -0.17% |
| Jun 30, 2021 | -0.24% |
| Mar 31, 2021 | -0.23% |
| Dec 31, 2020 | -0.06% |
| Sep 30, 2020 | -0.33% |
| Jun 30, 2020 | -0.19% |
| Mar 31, 2020 | -0.27% |
| Dec 31, 2019 | -0.21% |
| Sep 30, 2019 | -0.15% |
| Jun 30, 2019 | -0.13% |
| Mar 31, 2019 | -3.92% |
| Dec 31, 2018 | -0.41% |
| Sep 30, 2018 | 2.21% |
| Jun 30, 2018 | 21.18% |
| Mar 31, 2018 | 40.49% |
| Dec 31, 2017 | 20.96% |
| Sep 30, 2017 | 43.72% |
| Jun 30, 2017 | 40.59% |
| Mar 31, 2017 | 36.43% |
| Dec 31, 2016 | 40.46% |
| Sep 30, 2016 | 27.97% |
| Jun 30, 2016 | 28.08% |
| Mar 31, 2016 | 32.14% |
| Dec 31, 2015 | 70.19% |
| Sep 30, 2015 | 43.16% |
| Jun 30, 2015 | 27.60% |
| Dec 31, 2014 | 45.13% |